GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yili Chuannig Biotechnology Co Ltd (SZSE:301301) » Definitions » Additional Paid-In Capital

Yili Chuannig Biotechnology Co (SZSE:301301) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Yili Chuannig Biotechnology Co Additional Paid-In Capital?


Yili Chuannig Biotechnology Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥3,229 Mil) but then stayed the same from Dec. 2023 (¥3,229 Mil) to Mar. 2024 (¥0 Mil).

Yili Chuannig Biotechnology Co's annual additional paid-in capital declined from Dec. 2021 (¥12,153 Mil) to Dec. 2022 (¥3,229 Mil) but then stayed the same from Dec. 2022 (¥3,229 Mil) to Dec. 2023 (¥3,229 Mil).

Yili Chuannig Biotechnology Co Additional Paid-In Capital Historical Data

The historical data trend for Yili Chuannig Biotechnology Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yili Chuannig Biotechnology Co Additional Paid-In Capital Chart

Yili Chuannig Biotechnology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 2,050.61 12,152.94 12,152.94 3,229.47 3,229.47

Yili Chuannig Biotechnology Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3,229.47 - 3,229.47 -

Yili Chuannig Biotechnology Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Yili Chuannig Biotechnology Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Yili Chuannig Biotechnology Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Yili Chuannig Biotechnology Co (SZSE:301301) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yili Chuannig Biotechnology Co Ltd (SZSE:301301) » Definitions » Additional Paid-In Capital
Comparable Companies
SHSE:688520 SZSE:301207 SZSE:300009 SHSE:688278 SZSE:000403 SHSE:688578 SHSE:688166 SHSE:688639 SHSE:688177 SZSE:300294 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 516, Almatua Village, Yining Park, Horgos Economic Development Zone, Xinjiang, Ili, CHN, 835000
Website
http://www.klcnsw.com
Yili Chuannig Biotechnology Co Ltd adopts the most advanced and mature international biological fermentation, chemical extraction, enzymatic hydrolysis, control and energy saving, and environmental protection technology. The main products of the company include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, and crude ursodeoxycholic acid.

Yili Chuannig Biotechnology Co (SZSE:301301) Headlines

No Headlines